Related by context. Frequent words. (Click for all words.) 62 TranSwitch indebtedness 61 ELEVESS 60 Poly ICR 60 MOZOBIL 60 Plenaxis R 59 ELADUR 58 Eligard R 58 IoGen 57 Daytrana TM 57 MONOVISC 57 OLEPTRO TM 57 Aurexis 57 faropenem 57 vosaroxin 57 VANTAS 57 Bicifadine 57 Actimmune R 57 visit www.PAREXEL.com 57 RXi Pharmaceutical Corporation 57 vernakalant iv 56 BrachySil 56 risks anduncertainties 56 vernakalant oral 56 AeroLEF R 56 Fortical 56 regulatory authorizations 56 ZEGERID Powder 56 ZEGERID 56 Rotarix R 56 Resverlogix Corp. 56 Palatin Technologies Inc. 56 TOCOSOL Paclitaxel 56 Anika Therapeutics 55 ATryn ® 55 Tombstone Exploration Corporation 55 Icatibant 55 talactoferrin 55 ONTAK 55 PLAVIX R 55 R sorafenib tablets 55 Octreotide 55 Entereg R 55 ZYFLO CR 55 EPIX Pharmaceuticals 55 TRANSDUR Sufentanil 55 CUBICIN 55 Bioenvision compounds under 55 Coreg CR 55 forodesine 54 please visit www.ford.com 54 concerning Alnylam 54 Eduard Korsinsky Esq 54 Oracea 54 StaphVAX 54 Shigamabs ® 54 isavuconazole 54 TRISENOX 54 PROVIGIL 54 NUVIGIL 54 SILENOR TM 54 GLUMETZA 54 Palatin Technologies 54 obj obj = 54 Sinobiomed 54 Enablex 54 dalbavancin 54 Phenoptin 54 ONSOLIS 54 www.patheon.com 54 Kuvan R 54 TheCompany 53 Allovectin 7 R 53 Elevess 53 Oncolytics please 53 PD2i Analyzer ™ 53 OFIRMEV 53 SCOLR Pharma 53 Visudyne R 53 Genitope Corporation 53 Phase IIa clinical trials 53 FavId 53 Celsion Corporation 53 Nortel strategic alliances 53 Æterna Zentaris 53 Multiferon R 53 Topical Interferon Alpha 2b 53 SARMs 53 Fibrillex TM 53 Omigard 53 CorMedix 53 Exelbine 53 Zelrix 53 CPL Biologicals 53 SANCTURA XR 53 elotuzumab 53 theforward looking 53 omecamtiv mecarbil 53 intravenous formulations 53 PREOS 53 DSL.net s 53 InKine